GENEVA--(BUSINESS WIRE)--Acrongenomics Inc., (OTCBB:AGNM) Molecular Vision Ltd. and Pearson Matthews Ltd., announce today that they have joined forces to design a fully-manufacturable, prototype, point-of-care medical diagnostic device suitable for detecting kidney and cardiac biomarkers.
